Page last updated: 2024-08-17

carbostyril and Graves Ophthalmopathy

carbostyril has been researched along with Graves Ophthalmopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichinose, A; Kakizaki, H; Takahashi, Y1
Dayan, CM; Ji, QH; Lane, C; Ludgate, M; Morris, D; Ruge, F; Tee, AR; Zhang, L1

Other Studies

2 other study(ies) available for carbostyril and Graves Ophthalmopathy

ArticleYear
Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
    American journal of ophthalmology, 2014, Volume: 157, Issue:4

    Topics: Administration, Topical; Adult; Aged; Alanine; Antioxidants; Female; Fluorescein; Fluorescent Dyes; Graves Ophthalmopathy; Humans; Keratoconjunctivitis; Limbus Corneae; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Quinolones; Retrospective Studies; Rose Bengal; Tears; Treatment Outcome

2014
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:1

    Topics: Adipogenesis; Adult; Female; Forkhead Transcription Factors; Glucuronosyltransferase; Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Hyaluronic Acid; In Vitro Techniques; Middle Aged; Phosphatidylinositol 3-Kinase; Quinolones; Receptors, Thyrotropin; RNA, Small Interfering; Subcutaneous Fat; Transcriptional Activation; Trifluoperazine

2016